PL354519A1 - Związki 1-cyklicznego amino-alkilocykloheksanu, ich kompozycje farmaceutyczne i ich zastosowanie jako środki przeciwdrgawkowe - Google Patents

Związki 1-cyklicznego amino-alkilocykloheksanu, ich kompozycje farmaceutyczne i ich zastosowanie jako środki przeciwdrgawkowe

Info

Publication number
PL354519A1
PL354519A1 PL99354519A PL35451999A PL354519A1 PL 354519 A1 PL354519 A1 PL 354519A1 PL 99354519 A PL99354519 A PL 99354519A PL 35451999 A PL35451999 A PL 35451999A PL 354519 A1 PL354519 A1 PL 354519A1
Authority
PL
Poland
Prior art keywords
cyclic amino
compounds
pharmaceutical compositions
alleviation
alkyl
Prior art date
Application number
PL99354519A
Other languages
English (en)
Other versions
PL199587B1 (pl
Inventor
Markus Gold
Wojciech Danysz
Christopher Graham Raphael Parsons
Ivars Kalvinsh
Valerjans Kauss
Aigars Jirgensons
Original Assignee
Merz Pharma Gmbh & Co.Kgaa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merz Pharma Gmbh & Co.Kgaa filed Critical Merz Pharma Gmbh & Co.Kgaa
Publication of PL354519A1 publication Critical patent/PL354519A1/pl
Publication of PL199587B1 publication Critical patent/PL199587B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/033—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4453—Non condensed piperidines, e.g. piperocaine only substituted in position 1, e.g. propipocaine, diperodon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL354519A 1999-11-01 1999-11-01 Związek 1-cykliczny aminoalkilocykloheksanowy, sposób jego wytwarzania, kompozycja farmaceutyczna i zastosowanie związku 1-cyklicznego aminoalkilocykloheksanowego PL199587B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP1999/008317 WO2001032640A1 (en) 1999-11-01 1999-11-01 1-cyclic amino-alkylcyclohexane compounds, pharmaceutical compositions thereof, and their use as anticonvulsants

Publications (2)

Publication Number Publication Date
PL354519A1 true PL354519A1 (pl) 2004-01-26
PL199587B1 PL199587B1 (pl) 2008-10-31

Family

ID=8167482

Family Applications (1)

Application Number Title Priority Date Filing Date
PL354519A PL199587B1 (pl) 1999-11-01 1999-11-01 Związek 1-cykliczny aminoalkilocykloheksanowy, sposób jego wytwarzania, kompozycja farmaceutyczna i zastosowanie związku 1-cyklicznego aminoalkilocykloheksanowego

Country Status (24)

Country Link
EP (1) EP1228052B1 (pl)
JP (1) JP4043236B2 (pl)
KR (1) KR100548600B1 (pl)
CN (1) CN1264827C (pl)
AT (1) ATE361284T1 (pl)
AU (1) AU782760B2 (pl)
CA (1) CA2389325C (pl)
CY (1) CY1106672T1 (pl)
CZ (1) CZ20021533A3 (pl)
DE (1) DE69936004T2 (pl)
DK (1) DK1228052T3 (pl)
EA (1) EA005684B1 (pl)
ES (1) ES2285870T3 (pl)
HK (1) HK1049160B (pl)
HU (1) HUP0203275A3 (pl)
IL (2) IL149401A0 (pl)
MX (1) MXPA02004368A (pl)
NO (1) NO322359B1 (pl)
PL (1) PL199587B1 (pl)
PT (1) PT1228052E (pl)
SI (1) SI1228052T1 (pl)
TW (1) TWI242547B (pl)
UA (1) UA72558C2 (pl)
WO (1) WO2001032640A1 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7732162B2 (en) 2003-05-05 2010-06-08 Probiodrug Ag Inhibitors of glutaminyl cyclase for treating neurodegenerative diseases
US8278345B2 (en) 2006-11-09 2012-10-02 Probiodrug Ag Inhibitors of glutaminyl cyclase
ATE554085T1 (de) 2006-11-30 2012-05-15 Probiodrug Ag Neue inhibitoren von glutaminylcyclase
JP5930573B2 (ja) 2007-03-01 2016-06-15 プロビオドルグ エージー グルタミニルシクラーゼ阻害剤の新規使用
WO2008128985A1 (en) 2007-04-18 2008-10-30 Probiodrug Ag Thiourea derivatives as glutaminyl cyclase inhibitors
PL2475428T3 (pl) 2009-09-11 2015-12-31 Probiodrug Ag Pochodne heterocykliczne jako inhibitory cyklazy glutaminowej
ES2586231T3 (es) 2010-03-03 2016-10-13 Probiodrug Ag Inhibidores de glutaminil ciclasa
MX2012010470A (es) 2010-03-10 2012-10-09 Probiodrug Ag Inhibidores heterociclicos d ciclasa de glutaminilo (qc, ec .3 2. 5).
US8541596B2 (en) 2010-04-21 2013-09-24 Probiodrug Ag Inhibitors
EP2686313B1 (en) 2011-03-16 2016-02-03 Probiodrug AG Benzimidazole derivatives as inhibitors of glutaminyl cyclase
CN104211663B (zh) * 2014-08-11 2017-01-11 杭州偶联医药科技有限公司 一种(s)-n-甲氧基-甲基-2-(四氢吡咯基)丙酰胺及其制备方法和应用
PL3461819T3 (pl) 2017-09-29 2020-11-30 Probiodrug Ag Inhibitory cyklazy glutaminylowej
RU2714135C1 (ru) * 2019-11-22 2020-02-12 Федеральное государственное бюджетное учреждение науки "Институт токсикологии Федерального медико-биологического агентства" Гидрохлорид (1-метилпиперидин-4-ил)-2-пропилпентаноата, обладающий холинолитической и противосудорожной активностью

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3097207A (en) * 1958-03-06 1963-07-09 Parke Davis & Co 1-halophenyl and 1-alkoxyphenyl cyclohexylamines
UA61962C2 (uk) * 1997-06-30 2003-12-15 Мерц Фарма Гмбх Унд Ко. Кгаа Сполука 1-аміноалкілциклогексану, фармацевтична композиція на її основі та спосіб лікування

Also Published As

Publication number Publication date
ATE361284T1 (de) 2007-05-15
CN1264827C (zh) 2006-07-19
IL149401A (en) 2008-03-20
KR100548600B1 (ko) 2006-02-01
AU1158500A (en) 2001-05-14
AU782760B2 (en) 2005-08-25
JP4043236B2 (ja) 2008-02-06
NO20022044D0 (no) 2002-04-30
CZ20021533A3 (cs) 2002-08-14
NO322359B1 (no) 2006-09-18
EP1228052A1 (en) 2002-08-07
ES2285870T3 (es) 2007-11-16
PT1228052E (pt) 2007-05-31
EP1228052B1 (en) 2007-05-02
HUP0203275A2 (hu) 2003-01-28
DE69936004D1 (de) 2007-06-14
DE69936004T2 (de) 2008-01-10
NO20022044L (no) 2002-04-30
HK1049160B (zh) 2006-11-17
CA2389325C (en) 2007-01-09
IL149401A0 (en) 2002-11-10
HUP0203275A3 (en) 2003-11-28
TWI242547B (en) 2005-11-01
PL199587B1 (pl) 2008-10-31
HK1049160A1 (en) 2003-05-02
EA005684B1 (ru) 2005-04-28
SI1228052T1 (sl) 2007-10-31
KR20020063172A (ko) 2002-08-01
EA200200522A1 (ru) 2002-10-31
JP2003513083A (ja) 2003-04-08
WO2001032640A1 (en) 2001-05-10
CY1106672T1 (el) 2012-05-23
MXPA02004368A (es) 2002-11-14
CA2389325A1 (en) 2001-05-10
DK1228052T3 (da) 2007-06-18
UA72558C2 (uk) 2005-03-15
CN1374956A (zh) 2002-10-16

Similar Documents

Publication Publication Date Title
CY1106672T1 (el) Ενωσεις 1-κυκλικου αμινο-αλκυλοκυκλοεξανιου, φαρμακευτικες συνθεσεις αυτων και η χρηση τους ως αντισπασμωδικα
ITMI922006A1 (it) Esteri nitrici di derivati dell'acido 2-(2, 6-di-alo-fenilammino) fenilacetico e procedimento per la loro preparazione
EP1361220A4 (en) CYCLIC COMPOUNDS WITH THROMBOPOIETIN RECEPTAGONISM
PT96001A (pt) Processo para a preparacao de derivados de isoquinolina condensada com um anel carbociclico
EP1036794A4 (en) 2-ARYL-8-OXODIHYDROPURIN DERIVATIVES, THEIR PRODUCTION, THEIR USE AS MEDICINE COMPONENTS AND THEIR INTERMEDIATES
EP1207155A4 (en) DRUG COMPOSITIONS HAVING AGONIST THROMBOPOIETINE ACTIVITY
MXPA04001258A (es) Activador para el receptor d que responde al proliferador de peroxisoma.
MXPA04003398A (es) Activador para el receptor o activado con el proliferador de peroxisoma.
AU2337197A (en) Cinnamic acid derivatives and their use as integrin antagonists
IL133623A0 (en) Antithrombotic agents
MX9801716A (es) Derivados de meta-guanidina, urea, tiourea o acido aminobenzoico azaciclico, como antagonistas de integrina.
EP0999834A4 (en) ANTITHROMOSIS
DE69528257D1 (de) KONDENSIERTE HETEROCYCLISCHE VERBINDUNG, DEREN HERSTELLUNG UND VERWENDUNG ALS GnRH ANTAGONISTEN
AU2267495A (en) Benzamide derivatives as vasopressin antagonists
HUT65351A (en) Process for preparing ethanolamine derivatives haring sympathominetic and anti-pollakiuria activity and pharmaceutical compositions containing them as active agent
AU672052B2 (en) Antidepressant and antiparkinsonian compounds
SI1233953T1 (en) Novel benzothiadiazine derivatives, preparation method and pharmaceutical compositions containing same
CA2226886A1 (en) N-(4-substituted-benzyl)-2-aminolactam derivatives
AU3191293A (en) New naphthalene amides and sulphonamides, processes for their preparation and pharmaceutical compositions containing them
CR20230218A (es) Nuevos derivados de indazol acetileno
TR200002808T2 (tr) İlaç olarak yararlı C11 oksimil ve hidroksilamino prostaglandinleri
MX9600816A (es) Nuevos derivados triciclicos, su preparacion, su aplicacion a la preparacion de la colquicina y de la tiocolquicina, opticamente activas o racemicas, y de compuestos analogos o derivados e intermedios.
FI945582A0 (fi) Substituoidut (aryylialkyyliaminobentsyyli) aminopropioniamidijohdannaiset, niiden valmistus ja käyttö anti-epileptisinä, neuroprotektiivisina ja antidepressiivisina aineina
HUT61018A (en) Process for producing 3-/1-thiazolidinylbutyl-4-piperazinyl/1-h-indazole derivatives and pharmaceutical compositions comprising such compounds as active ingredient
HUT60491A (en) Process for producing substituted n-benzylindole derivatives having leukotriene antagonist effect and pharmaceutical compositions comprising such compounds

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20091101